The microfluidic approach offered by this invention eliminates the problem of diffusion-based antibody-antigen binding interactions, and offers shorter reaction times. Furthermore, this invention uses small sample volumes that do not need prior purification.
[更多]
| |<首頁 <-上一頁 下一頁-> 末頁>| |
